Current Report Filing (8-k)
September 13 2017 - 4:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 11, 2017
BIOSOLAR,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-54819
|
|
20-4754291
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
incorporation)
|
|
|
|
Identification
No.)
|
27936
Lost Canyon Road, Suite 202, Santa Clarita, CA 91387
(Address
of principal executive offices and Zip Code)
Registrant's
telephone number, including area code:
(661) 251-0001
Copies
to:
Gregory
Sichenzia, Esq.
Marcelle
S. Balcombe, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway, 32
nd
Floor
New
York, New York 10006
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
As
previously disclosed on a Current Report on Form 8-K, on August 23, 2016, BioSolar, Inc. (the “Company”) announced
that the Company entered into a research agreement (the “Agreement”), effective August 17, 2016, with North Carolina
Agricultural and Technical State University, a constituent member of the University of North Carolina system (the “University”).
On September 11, 2017, the Company and the University extended the initial term of the Agreement for another twelve months, through
September 11, 2018.
The
Company shall continue to sponsor the University’s project which shall include the research, testing and evaluation of a
proposal (the “Project”). Total costs to the Company for the extended term are not to exceed the sum of $159,610.
The Agreement may be further extended upon mutual agreement by the parties and may be terminated upon terminated due to the inability
of the principal investigator to continue the Project, and a mutually acceptable substitute is not available, or upon thirty (30)
days prior written notice by either party to the other.
The
foregoing summary of the terms of the Agreement are subject to, and qualified in its entirety by, such document attached hereto
as Exhibit 10.1 and incorporated herein by reference.
On
September 13, 2017, the Company issued a press release with respect to the foregoing. A copy of the press release is included
hereto as Exhibit 99.1.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BIOSOLAR, INC.
|
|
|
Date: September 13, 2017
|
/s/
David Lee
|
|
David Lee
|
|
Chief Executive Officer
|
3